0001493152-24-003170.txt : 20240122 0001493152-24-003170.hdr.sgml : 20240122 20240122154255 ACCESSION NUMBER: 0001493152-24-003170 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240122 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001419051 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 451226465 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54554 FILM NUMBER: 24548656 BUSINESS ADDRESS: STREET 1: 701 WILD ROSE LANE CITY: ELK CITY STATE: ID ZIP: 83525 BUSINESS PHONE: (760) 295-7208 MAIL ADDRESS: STREET 1: 701 WILD ROSE LANE CITY: ELK CITY STATE: ID ZIP: 83525 FORMER COMPANY: FORMER CONFORMED NAME: Friendly Auto Dealers, Inc. DATE OF NAME CHANGE: 20071120 8-K 1 form8-k.htm
false 0001419051 0001419051 2024-01-22 2024-01-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported January 22, 2024

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

 

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   000-54554   45-1226465
(State or other jurisdiction of incorporation or organization)  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

 

701 Wild Rose Lane

Elk City, Idaho 83525

 

(Address of Principal Executive Offices and Zip Code)

 

(760) 295-7208

 

(Issuer’s telephone number)

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock  

TSOI

   OTC Markets

 

 

 

 
 

 

Item 8.01 Other Events.

 

The filing of a Civil Action in the Superior Court of the State of California for the County of San Diego Case No.: 37-2023-00045520 CU-DF-NC. Stocktwits.com, InvestorsHub.com Inc., and yahoo.com are websites that provide users the opportunity, through access to its message boards, to communicate with others concerning stock trading, corporate behavior, and other finance-related issues. The websites undoubtedly serve a useful purpose. But the message boards, which allow its users to express themselves anonymously, by using “screen names” and/or “usernames” traceable only through the hosts of the sites or their internet service providers (ISP), are an opportunity for fraud, trade libel, defamation, misinformation, and stock market manipulators.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: January 22, 2024

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

 

By: /s/ Timothy Dixon  
Timothy Dixon  
Chief Executive Officer  

 

 

 EX-101.SCH 2 tsoi-20240122.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 tsoi-20240122_def.xml XBRL DEFINITION FILE EX-101.LAB 4 tsoi-20240122_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 tsoi-20240122_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 22, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 22, 2024
Entity File Number 000-54554
Entity Registrant Name THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Entity Central Index Key 0001419051
Entity Tax Identification Number 45-1226465
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 701 Wild Rose Lane
Entity Address, City or Town Elk City
Entity Address, State or Province ID
Entity Address, Postal Zip Code 83525
City Area Code (760)
Local Phone Number 295-7208
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol TSOI
XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001419051 2024-01-22 2024-01-22 iso4217:USD shares iso4217:USD shares false 0001419051 8-K 2024-01-22 THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. NV 000-54554 45-1226465 701 Wild Rose Lane Elk City ID 83525 (760) 295-7208 false false false false Common Stock TSOI EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://therapeuticsolutionsint.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm tsoi-20240122.xsd tsoi-20240122_lab.xml tsoi-20240122_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "tsoi", "nsuri": "http://therapeuticsolutionsint.com/20240122", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "tsoi-20240122.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "tsoi-20240122_lab.xml" ] }, "presentationLink": { "local": [ "tsoi-20240122_pre.xml" ] } }, "keyStandard": 20, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 20 }, "report": { "R1": { "role": "http://therapeuticsolutionsint.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://therapeuticsolutionsint.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-003170-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-003170-xbrl.zip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